|
WO1998024788A1
(en)
*
|
1996-12-02 |
1998-06-11 |
Georgetown University |
Tropane derivatives and method for their synthesis
|
|
WO1999065492A1
(en)
|
1998-06-19 |
1999-12-23 |
Eli Lilly And Company |
Inhibition of serotonin reuptake
|
|
US6218383B1
(en)
*
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
|
DE69914935T2
(de)
*
|
1998-11-27 |
2009-10-01 |
Neurosearch A/S |
8-azabicyclo[3.2.1]okt-2-en- und -oktanderivate
|
|
US6432975B1
(en)
*
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
EP1149095B1
(en)
*
|
1999-01-28 |
2004-01-21 |
Neurosearch A/S |
Novel azabicyclo derivatives and their use
|
|
EP1147112B1
(en)
*
|
1999-01-29 |
2003-10-29 |
Abbott Laboratories |
Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
|
|
US7265115B2
(en)
|
1999-01-29 |
2007-09-04 |
Abbott Laboratories |
Diazabicyclic CNS active agents
|
|
NZ513575A
(en)
*
|
1999-05-04 |
2003-07-25 |
Neurosearch As |
Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
|
|
US6890935B2
(en)
|
1999-11-01 |
2005-05-10 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
MY145722A
(en)
*
|
2000-04-27 |
2012-03-30 |
Abbott Lab |
Diazabicyclic central nervous system active agents
|
|
ATE287888T1
(de)
*
|
2000-07-04 |
2005-02-15 |
Neurosearch As |
Aryl- und heteroaryldiazabicycloalkane, deren zubereitung und verwendung
|
|
EP1358177B1
(en)
*
|
2000-10-13 |
2006-08-02 |
NeuroSearch A/S |
Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
|
|
CZ2004408A3
(cs)
*
|
2001-10-02 |
2005-03-16 |
Pharmacia & Upjohn Company |
Azabicyklicky substituované kondenzované heteroarylsloučeniny
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
JP2005523288A
(ja)
|
2002-02-19 |
2005-08-04 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
疾病治療用の縮合した二環式−n−架橋−複素環式芳香族カルボキサミド
|
|
AU2003222738B2
(en)
|
2002-05-07 |
2009-09-17 |
Neurosearch A/S |
Novel azacyclic ethynyl derivatives
|
|
GB2398636A
(en)
*
|
2003-02-21 |
2004-08-25 |
Ipsen Ltd |
Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample
|
|
EP1601664B1
(en)
*
|
2003-02-28 |
2008-04-30 |
Schering Corporation |
Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
|
|
BRPI0408248A
(pt)
|
2003-03-12 |
2006-03-01 |
Pfizer Prod Inc |
derivados azabicìclicos de piridiloximetila e de benzisoxazol
|
|
US20070191815A1
(en)
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
US20060173037A1
(en)
*
|
2005-01-10 |
2006-08-03 |
Nathalie Schlienger |
Aminophenyl derivatives as selective androgen receptor modulators
|
|
DE602006019561D1
(de)
|
2005-02-16 |
2011-02-24 |
Neurosearch As |
Diazabicyclische arylderivate und ihre verwendung als chinolinergische liganden an nikotin-acetylcholin-rezeptoren
|
|
DE102005007859A1
(de)
*
|
2005-02-21 |
2006-08-24 |
Lts Lohmann Therapie-Systeme Ag |
Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen
|
|
AU2006233884A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Neurosearch A/S |
(+) - and (-) -8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1.)oct-2-ene
|
|
FR2889701B1
(fr)
*
|
2005-08-12 |
2007-10-05 |
Sanofi Aventis Sa |
Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
|
|
CA2632642A1
(en)
|
2005-12-06 |
2007-06-14 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives and their medical use
|
|
US20070134169A1
(en)
*
|
2005-12-11 |
2007-06-14 |
Rabinoff Michael D |
Methods for smoking cessation or alcohol cessation or other addiction cessation
|
|
US7687523B2
(en)
|
2006-02-10 |
2010-03-30 |
Neurosearch A/S |
3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
|
|
EP1984365A1
(en)
|
2006-02-10 |
2008-10-29 |
NeuroSearch A/S |
3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
|
|
WO2007090887A1
(en)
|
2006-02-10 |
2007-08-16 |
Neurosearch A/S |
3, 9-diazabicyclo [3.3. 1]nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
|
|
KR20090013827A
(ko)
*
|
2006-06-12 |
2009-02-05 |
화이자 프로덕츠 인크. |
Hiv 환자에서 면역 재구성을 증진시키고 기회 감염을 치료하기 위한 ccr5 길항제
|
|
EP1977746B8
(en)
|
2007-04-02 |
2014-09-24 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
|
TWI415850B
(zh)
*
|
2007-07-20 |
2013-11-21 |
Theravance Inc |
製備mu類鴉片受體拮抗劑之中間物的方法
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
US8697722B2
(en)
*
|
2007-11-02 |
2014-04-15 |
Sri International |
Nicotinic acetylcholine receptor modulators
|
|
JP5421368B2
(ja)
*
|
2008-08-01 |
2014-02-19 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
テトラヒドロピリジニルおよびジヒドロピロリル化合物およびそれらの使用
|
|
CN102216295A
(zh)
*
|
2008-11-18 |
2011-10-12 |
神经研究公司 |
8-氮杂双环[3.2.1]辛-2-烯衍生物及其作为单胺神经递质再摄取抑制剂的用途
|
|
HUE026815T2
(en)
|
2008-11-19 |
2016-07-28 |
Forum Pharmaceuticals Inc |
Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
|
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
|
AU2010247835A1
(en)
*
|
2009-05-11 |
2011-12-08 |
Envivo Pharmaceuticals, Inc. |
Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
|
|
WO2011085389A1
(en)
*
|
2010-01-11 |
2011-07-14 |
Astraea Therapeutics, Llc |
Nicotinic acetylcholine receptor modulators
|
|
TWI519532B
(zh)
|
2010-05-17 |
2016-02-01 |
艾維沃製藥公司 |
(R)-7-氯-N-(啶-3-基)苯並[b]噻吩-2-羧醯胺鹽酸鹽單水合物之結晶形體
|
|
RU2017136693A
(ru)
|
2012-05-08 |
2019-02-08 |
Форум Фармасьютикалз, Инк. |
Способы поддержания, лечения или улучшения когнитивной функции
|
|
WO2014011768A1
(en)
*
|
2012-07-10 |
2014-01-16 |
Adispell, Inc. |
Anti-anxiety treatment
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
薬剤送達方法及びシステム
|
|
US9724340B2
(en)
|
2015-07-31 |
2017-08-08 |
Attenua, Inc. |
Antitussive compositions and methods
|
|
WO2018129304A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
AU2019279884B2
(en)
|
2018-05-29 |
2025-01-30 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
JP2022507660A
(ja)
|
2018-11-16 |
2022-01-18 |
モーニングサイド ベンチャー インベストメンツ リミテッド |
温度によって調節される経皮薬剤送達システム
|
|
KR102272452B1
(ko)
|
2020-12-11 |
2021-07-05 |
(주)예광솔라 |
스파이럴 파일 공법 및 이에 적용되는 스파이럴 파일
|
|
KR200497569Y1
(ko)
|
2021-02-18 |
2023-12-21 |
주식회사 알파인랩 |
지주 기초용 스크루 파일
|